7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... Recent infection • Pulmonary ... inhibitors • Injection drug ... • HIV: 2/3 pulmonary ... characteristic features Clinical
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... Recent infection • Pulmonary ... inhibitors • Injection drug ... • HIV: 2/3 pulmonary ... characteristic features Clinical
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
Inflammatory Syndrome - Overview ... noncompliance • Clinical ... initiation Clinical ... , pulmonary infiltrates ... lymphadenitis, pulmonary
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
drugs after consultation ... HIV-infected persons with clinical ... Please refer to the table ... below for TB drug ... infections #HIVAIDS #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... have achieved negative ... #differential #algorithm ... cardiology #treatment #table ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
disease based on clinical ... necessary based on drug-drug ... please refer to Table ... Note: Active TB ... infections #HIVAIDS #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... , hypokalemia, negative ... • Therapeutic drug ... tolerable • Limited clinical ... #pharmacology